BONDANZA, ATTILIO
 Distribuzione geografica
Continente #
AS - Asia 4.329
EU - Europa 4.160
NA - Nord America 3.955
SA - Sud America 1.217
AF - Africa 97
Continente sconosciuto - Info sul continente non disponibili 93
OC - Oceania 12
Totale 13.863
Nazione #
US - Stati Uniti d'America 3.703
RU - Federazione Russa 2.230
SG - Singapore 1.628
CN - Cina 1.309
BR - Brasile 983
IT - Italia 620
SE - Svezia 580
HK - Hong Kong 526
VN - Vietnam 418
FR - Francia 202
DE - Germania 141
CA - Canada 119
GB - Regno Unito 101
AR - Argentina 96
BD - Bangladesh 90
IN - India 89
JP - Giappone 58
EC - Ecuador 49
FI - Finlandia 48
AT - Austria 46
MX - Messico 46
NL - Olanda 40
IE - Irlanda 37
ZA - Sudafrica 37
ID - Indonesia 36
IQ - Iraq 35
CO - Colombia 26
PL - Polonia 23
PY - Paraguay 23
JM - Giamaica 21
MA - Marocco 19
TR - Turchia 19
UA - Ucraina 16
ES - Italia 14
UZ - Uzbekistan 14
IL - Israele 13
PK - Pakistan 12
SA - Arabia Saudita 12
VE - Venezuela 12
CR - Costa Rica 10
DZ - Algeria 10
CL - Cile 9
PR - Porto Rico 9
SV - El Salvador 9
TN - Tunisia 9
UY - Uruguay 9
EG - Egitto 8
MY - Malesia 8
AU - Australia 7
GT - Guatemala 7
IR - Iran 7
PE - Perù 7
TT - Trinidad e Tobago 7
AZ - Azerbaigian 6
DO - Repubblica Dominicana 6
KE - Kenya 6
LT - Lituania 6
PH - Filippine 6
CH - Svizzera 5
HN - Honduras 5
HU - Ungheria 5
KW - Kuwait 5
NZ - Nuova Zelanda 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
BA - Bosnia-Erzegovina 4
BB - Barbados 4
BY - Bielorussia 4
JO - Giordania 4
KZ - Kazakistan 4
LV - Lettonia 4
NP - Nepal 4
SY - Repubblica araba siriana 4
AM - Armenia 3
BE - Belgio 3
BH - Bahrain 3
CZ - Repubblica Ceca 3
GR - Grecia 3
NI - Nicaragua 3
PT - Portogallo 3
RO - Romania 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
BO - Bolivia 2
DK - Danimarca 2
EE - Estonia 2
KH - Cambogia 2
KR - Corea 2
LB - Libano 2
MD - Moldavia 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
BF - Burkina Faso 1
BG - Bulgaria 1
BS - Bahamas 1
BW - Botswana 1
CI - Costa d'Avorio 1
CY - Cipro 1
DM - Dominica 1
ET - Etiopia 1
Totale 13.758
Città #
Singapore 583
Ashburn 561
Hong Kong 520
Moscow 513
San Jose 415
Dallas 389
Shanghai 255
Council Bluffs 205
Milan 201
Hefei 194
Lawrence 185
Princeton 185
Lauterbourg 161
Beijing 151
Ho Chi Minh City 146
New York 142
Hanoi 77
São Paulo 70
Santa Clara 69
Los Angeles 58
Phoenix 56
Miano 38
Nuremberg 38
Rio de Janeiro 38
Dublin 34
Boardman 29
Brooklyn 29
Orem 27
Helsinki 26
Montreal 26
North Bergen 24
Chennai 23
Guangzhou 23
Tokyo 23
Da Nang 22
London 22
Munich 22
Belo Horizonte 21
Johannesburg 21
Seattle 21
Brasília 20
Quito 20
Atlanta 19
Guayaquil 18
Warsaw 18
Boston 17
Haiphong 17
Rome 17
The Dalles 17
Vienna 17
Washington 17
Biên Hòa 16
Turku 16
Curitiba 15
Toronto 15
Chicago 14
Kingston 13
Mexico City 13
Campinas 12
Denver 12
Frankfurt am Main 12
Naples 12
Poplar 12
Porto Alegre 12
San Francisco 12
Tashkent 12
Baghdad 11
Can Tho 10
Guarulhos 10
Hangzhou 10
Philadelphia 10
Shenzhen 10
Shijiazhuang 10
Amsterdam 9
Ankara 9
Buenos Aires 9
Goiânia 9
Hải Dương 9
Manchester 9
Salvador 9
Stockholm 9
Xi'an 9
Zhengzhou 9
Bologna 8
Buffalo 8
Fortaleza 8
Houston 8
Jiaxing 8
Montevideo 8
Newark 8
Recife 8
Charlotte 7
Detroit 7
Mumbai 7
Queens 7
Reston 7
San José 7
San Juan 7
Santo André 7
Tianjin 7
Totale 6.326
Nome #
CD4 CAR-T cells targeting CD19 play a key role in exacerbating cytokine release syndrome, while maintaining long-term responses 239
Loss of mismatched HLA in leukemia after stem-cell transplantation 237
Rapamycin-Based GvHD Prophylaxis Is Effective in T-Cell Replete Unmanipulated Haploidentical Peripheral Stem Cell Transplantation for Advanced Haematological Malignancies: Results in 46 Patients 225
Disrupting N-glycan expression on tumor cells boosts chimeric antigen receptor T cell efficacy against solid malignancies 216
Clinical impact of suicide gene therapy in allogeneic hematopoietic stem cell transplantation 185
Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study 185
A New Clinicobiological Scoring System for the Prediction of Infection-Related Mortality and Survival after Allogeneic Hematopoietic Stem Cell Transplantation 171
Sirolimus-based graft-versus-host disease prophylaxis promotes the in vivo expansion of regulatory T cells and permits peripheral blood stem cell transplantation from haploidentical donors 153
Anti-beta 2 glycoprotein I antibodies cause inflammation and recruit dendritic cells in platelet clearance 151
Autologous hematopoietic stem cell transplantation in neuromyelitis optica: A registry study of the EBMT Autoimmune Diseases Working Party 138
A phase II multicenter trial of HSV-TK engineered donor lymphocytes after haplo-identical HSCT: Early immune reconstitution and abrogation of GvHD 132
Adoptive immunotherapy with genetically modified lymphocytes in allogeneic stem cell transplantation 130
A novel self-lipid antigen targets human T cells against CD1c(+) leukemias 128
Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transfer 126
A dual role for genetically modified lymphocytes in cancer immunotherapy 126
CAR T cell manufacturing from naive/stem memory T lymphocytes enhances antitumor responses while curtailing cytokine release syndrome 124
Antitumor effects of HSV-TK-engineered donor lymphocytes after allogeneic stem-cell transplantation 121
Allogeneic hematopoietic stem cell transplantation for neuromyelitis optica. 116
IL-10-Engineered Human CD4+ Tr1 Cells Eliminate Myeloid Leukemia in an HLA Class I-Dependent Mechanism 116
Leukemic blasts secondary to myelodysplastic syndromes are molecularly programmed to differentiate into functionally mature dendritic cells 111
Allogeneic haematopoietic stem cell transplantation in refractory neuromyelitis optica spectrum disorders 110
Graft-versus leukemia effect of HLA-haploidentical central-memory T cells expanded with leukemic APCs and modified with a suicide gene 110
Beneficial role of CD8+ T-cell reconstitution after HLA-haploidentical stem cell transplantation for high-risk acute leukaemias: results from a clinico-biological EBMT registry study mostly in the T-cell-depleted setting 103
Oncogene-induced senescence in hematopoietic progenitors features myeloid restricted hematopoiesis, chronic inflammation and histiocytosis 103
T-N/SCM Pre-Selection Generates CAR T Cell Products Driving Superior Anti-Tumor Responses While Curtailing Severe CRS 99
Anti-beta 2 glycoprotein I antibodies prevent the de-activation of platelets and sustain their phagocytic clearance 99
An apoptotic cell threshold for dendritic cell maturation and function. 99
Application of Donor Lymphocytes Expressing a Suicide Gene for Early GvL Induction and Later Control of GvH reactions after Bone Marrow Tranaplantation 98
Acute Myeloid Leukemia Targeting by Chimeric Antigen Receptor T Cells: Bridging the Gap from Preclinical Modeling to Human Studies 98
CD4 CAR T Cells Drive Extensive CD8 CAR T Cell Expansion, Leading to Severe Cytokine Release Syndrome 96
IL-7 and IL-15 instruct the generation of human memory stem T cells from naive precursors 94
Autoantibody Production during Chronic Graft-Versus-Host Disease Does Not Associate with Long-Term Persistence of Host B Cells in Humans 93
NY-ESO-1 TCR single edited stem and central memory T cells to treat multiple myeloma without graft-versus-host disease 92
B- and T-cell interactions in graft-versus-host disease 91
Tracking genetically engineered lymphocytes long-term reveals the dynamics of T cell immunological memory 91
Early and Effective Immune-Recovery by Gene-Engineered Lymphocytes after Haploidentical Transplantation for Leukemia Abate Late Transplant Mortality 91
Editing Human Lymphocyte Specificity for Safe and Effective Adoptive Immunotherapy of Leukemia 91
Anti-phospholipid antibodies opsonize activated platelets for uptake by dendritic cells: relevance to epitope spreading in platelet autoimmunity. 90
Apoptotic cell-pulsed dendritic cells break tolerance and accelerate lupus in NZB/W F1 mice. 89
Erratum: Tracking genetically engineered lymphocytes long-term reveals the dynamics of T cell immunological memory (Science Translational Medicine (2015) 7:319 (319er9)) 89
The IL-1/IL-1 receptor axis and tumor cell released inflammasome adaptor ASC are key regulators of TSLP secretion by cancer associated fibroblasts in pancreatic cancer 88
Editing Human Lymphocyte Specificity for Safe and Effective Adoptive Immunotherapy of Leukemia 87
Editing Human Lymphocyte Specificity for Safe and Effective Adoptive Immunotherapy of Leukemia 87
Autologous haematopoietic stem cell transplantation in aggressive forms of neuromyelitis optica (NMO) and NMO spectrum disorders 86
Stability of human rapamycin-expanded CD4(+)CD25(+) T regulatory cells 86
Bone marrow central memory and memory stem T-cell exhaustion in AML patients relapsing after HSCT 85
TNF-alpha coupled to membrane of apoptotic cells favors the cross-priming to melanoma antigens 80
Th22 cells increase in poor prognosis multiple myeloma and promote tumor cell growth and survival 78
Immunoediting of the genomic and transcriptional profile of acute myeloid leukaemia in response to allogeneic haematopoietic stem cell transplantation 78
SUICIDE GENE TRANSFER INTO DONOR LYMPHOCYTES ALLOWS EARLY AND EFFECTIVE IMMUNE-RECONSTITUTION AFTER FAMILY HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR LEUKEMIAS: RESULTS OF THE TK007 STUDY 78
T Cell Suicide Gene Therapy Prompts Thymic Renewal in Adults After Haploidentical Hematopoietic Stem Cell Transplantation in the Absence of Post-Transplant Immunesuppression 77
Rapid and effective immune reconstitution with HSV-TK engineered donor lymphocyte add-backs after Haplo-HSCT 75
From TCR Gene Transfer to TCR Gene Editing of Central Memory T Lymphocytes for Immunotherapy of Leukemia 75
Enforced IL-10 Expression Confers Type 1 Regulatory T Cell (Tr1) Phenotype and Function to Human CD4(+) T Cells 75
Immune monitoring in allogeneic hematopoietic stem cell transplant recipients: a survey from the EBMT-CTIWP 75
Dual Transgenesis of T Cells with a CD44v6 CAR and a Suicide Gene for the Safe Eradication of Myeloid Leukemia and Myeloma 74
Improving the safety of cell therapy with the TK-suicide gene. 73
In-vivo T-regs generation by rapamycin-mycophenolate-ATG as a new platform for GvHD prophylaxis in T-cell repleted unmanipulated haploidentical peripheral stem cell transplantation: results in 59 patients 73
T Cell Receptor Gene Transfer into Early Differentiated Lymphocytes by Lentiviral Vectors for Safe and Effective Adoptive Immune Therapy of Leukemia 72
Jon van Rood (1926-2017) 72
Retroviral vector integration deregulates gene expression but has no consequence on the biology and function of transplanted T cells 71
CD4+ T cells from IPEX patients convert into functional and stable regulatory T cells by FOXP3 gene transfer 71
Extracellular NGFR spacers allow efficient tracking and enrichment of fully functional car-t cells co-expressing a suicide gene 71
Harnessing the reverse cholesterol transport pathway to favor differentiation of monocyte-derived APCs and antitumor responses 70
Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells 70
H1N1 vaccination post-allogeneic haematopoietic stem cell transplantation and the risk of GvHD 69
Temporal, quantitative and functional characteristics of Single-KIR positive alloreactive NK cell recovery account for impaired graft versus leukemia activity after haploidentical HSCT 69
Molecular modification of idiotypes from B-cell lymphomas for expression in mature dendritic cells as a strategy to induce tumor-reactive CD4(+) and CD8(+) T-cell responses 68
Generation of human memory stem T cells after haploidentical T-replete hematopoietic stem cell transplantation 68
CD44v6 is associated with chemoresistance induced by bone marrow-derived mesenchymal stromal cells 68
Editing human lymphocytes specificity for safe and effective adoptive immunoterapy of leukemia 67
Use of IL-7 and IL-15 for the genetic modification of memory T lymphocytes 67
Temporal, quantitative, and functional characteristics of single-KIR-positive alloreactive natural killer cell recovery account for impaired graft-versus-leukemia activity after haploidentical hematopoietic stem cell transplantation 66
IL-10-Engineered Human CD4+ Tr1 Cells Eliminate Myeloid Leukemia in an HLA Class I-Dependent Mechanism 66
Control of infectious mortality due to carbapenemase-producing Klebsiella pneumoniae in hematopoietic stem cell transplantation 66
Clinical pharmacology of CAR-T cells: linking cellular pharmacodynamics to pharmacokinetics and antitumor effects 65
Requirements for retroviral targeting of a suicide gene to alloreactive memory stem T cells for adoptive immunotherapy of leukemia 65
Genetic engineering of hematopoiesis for targeted IFN-α delivery inhibits breast cancer progression 65
Interferon gene therapy reprograms the leukemia microenvironment inducing protective immunity to multiple tumor antigens 65
Kinetics of acute and chronic GvHD control by ganciclovir in-vivo HSV-TK suicide gene activation: long-term GvHD-free survival in 57 patients after haploidentical TK-cells 65
uPA/uPAR system is active in immature dendritic cells derived from CD14(+)CD34(+) precursors and is down-regulated upon maturation 64
Overcoming the toxicity hurdles of genetically targeted T cells. 64
Naive-Derived Memory Stem T Cells: A Novel Promising Platform for Cancer Immune-Gene Therapy 63
T-cell suicide gene therapy prompts thymic renewal in adults after hematopoietic stem cell transplantation 63
TCR gene editing results in effective immunotherapy of leukaemia without the development of GvHD 63
Hematopoietic stem cell transplantation in its 60s: A platform for cellular therapies 63
Inflammation Converts Human Mesoangioblasts Into Targets of Alloreactive Immune Responses: Implications for Allogeneic Cell Therapy of DMD 62
Neuromyelitis optica remission after allo-SCT: results in 2 patients and correlation with T- and B-cell biomarkers of tolerance 62
Infusion of suicide gene-modified donor T cells promotes a rapid and effective immune reconstitution and provides long-term survival after haploidentical hemaopoietic cell transplantation for the cure of patients with high-risk leukemia 62
T Cell Receptor Gene Transfer into Naive and Central Memory Lymphocytes by Lentiviral Vectors for a Safe and Effective Adoptive Immune Therapy of Leukemia 62
Dual Transgenesis of T Cells with a Novel CD44v6-Specific Chimeric Antigen Receptor and a Suicide Gene for Safe and Effective Targeting of Chemoresistance in Hematopoietic Tumors 62
Mother Donors Improve Outcomes after HLA Haploidentical Transplantation: A Study by the Cellular Therapy and Immunobiology Working Party of the European Society for Blood and Marrow Transplantation 62
Safety and Efficacy of Donor T Cells Engineered with Herpes Simplex Virus Thymidine-Kinase Suicide Gene (TK Cells) Given after T-Cell Depleted (TCD) Haploidentical Hematopoietic Transplantation (Haplo-HSCT): Results of a 14-Year Follow-Up in 45 Patients 61
Dual transgenesis of T-cells with a CD44v6 CAR and a suicide gene for the safe eradication of myeloid leukaemia and myeloma 61
HAPLO-SCT WITH TK plus LYMPHOCYTES PRODUCE LEUKEMIA FREE SURVIVAL COMPARABLE TO UNRELATED BONE MARROW AND CORD BLOOD TRANSPLANTATION IN HIGH RISK ACUTE LEUKEMIA: 'TK007' PHASE II STUDY FINAL ANALYSIS 60
Harnessing CD1-restricted T cells for the immunotherapy of leukemia 59
Haploidentical HSCT: a 15-year experience at San Raffaele. 59
Immunostimulatory leukemic dendritic cells can efficiently expand leukemia-reactive T cells from HSCT donors 59
Editing Human Lymphocyte Specificity for Safe and Effective Adoptive Immunotherapy of Leukemia 59
IL-7 receptor expression identifies suicide gene-modified allospecific CD8(+) T cells capable of self-renewal and differentiation into antileukemia effectors 59
Totale 9.211
Categoria #
all - tutte 92.340
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 92.340


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022143 0 0 0 68 9 6 10 10 12 16 3 9
2022/20231.094 408 233 67 3 25 119 54 76 62 12 27 8
2023/2024567 26 22 49 52 50 114 59 51 8 30 22 84
2024/20252.647 306 30 34 113 71 186 309 218 477 373 258 272
2025/20267.670 582 626 718 1.231 511 222 604 523 1.993 327 171 162
2026/20271.665 153 491 378 643 0 0 0 0 0 0 0 0
Totale 13.863